Resultados de la búsqueda 401-410 of 15836 for endocrine disease
... disease and tissue at the time of any breast cancer recurrence. Cell Saver During Tumor Resection. Rochester, Minn. The aims of this study are to investigate ...
... disorders/hair-disorders/hirsutism-and-hypertrichosis. ... The Journal of Clinical Endocrinology and Metabolism. ... Evaluation and treatment of hirsutism in ...
Disorders of puberty. In: Nelson Textbook of Pediatrics. 21st ed ... https://www.endocrine.org/patient-engagement/endocrine-library/precocious-puberty.
... endocrine therapy. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The ...
Patients in the GDC-0199+R arm will continue GDC-0199 treatment until disease progression or 2 years since treatment start, whichever comes first.
Mayo Clinic Minute: Success in reducing heart disease deaths, except for young women Feb. 07, 2023, 05:30 p.m. CDT · What's National Wear Red Day? Feb. 03 ...
Centers for Disease Control and Prevention. https://www.cdc.gov/std/gonorrhea/stdfact-gonorrhea-detailed.htm. Accessed Sept. 21, 2023. Ghanem KG. Clinical ...
Patients will receive treatment until disease progression, unacceptable toxicity, consent withdrawal or death occurs. The study is expected to last ...
A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL). Jacksonville ...
... Disorder. Rochester, Minn. The ... There is a need for new treatments for myelofibrosis (MF) patients based on laboratory insight into disease pathogenesis.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?